A compound with the SMILES CCN1C[C@]2(CO)CC[C@H](OC)[C@@]34C2[C@H](OC)[C@@](O)(C13)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@@H]1[C@H]2OC has a hERG inhibition at a concentration of 10uM of 5.228%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCN1C[C@]2(CO)CC[C@H](OC)[C@@]34C2[C@H](OC)[C@@](O)(C13)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@@H]1[C@H]2OC
CCN1C[C@]2(CO)CC[C@H](OC)[C@@]34C2[C@H](OC)[C@@](O)(C13)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@@H]1[C@H]2OC
(1S,2R,3R,4S,5R,6S,8R,9S,13S,16S,18S)-11-ethyl-13-(hydroxymethyl)-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane-8,9-diol